Page 187 - book

Kharazmi Pharmaceutical Co.

IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY

Type Product Brand Dosage Strength Indication Status
Name
Form
Management of mi-
Sumatriptan Belatron® Tablet 50 mg Available
Analgesics & graine headache
Antipyretics Not
Tramadol Hydrochloride Tralgin® Capsule 50 mg Analgesic
Available
Macrolide Antibacterial
Azithromycin ZitoCidal® Tablet 250 mg Available
Agents
Macrolide Antibacterial
Azithromycin ZitoCidal® Capsule 250 mg Available
Agent
Macrolide Antibacterial
Azithromycin ZitoCidal® Tablet 500 mg Available
Agent
Macrolide Antibacterial
Clarithromycin PylorCidal® Tablet 500 mg Available
Agent
Macrolide Antibacterial
Erythromycin ----- Tablet 400 mg Available
Agent

Antibacterial Gemifloxacin Gemflo® Tablet 320 mg Quinolone Antibacterial Available
Agent
Agents
Levofloxacin TafexCidal® Tablet 500 mg Quinolone Antibacterial Available
Agent
Quinolone Antibacterial
Ciprofloxacin PuriqCidal® Tablet 500 mg,750mg Available
Agent
Co-Trimoxazole CotimetCi- Sulfonamide Antibacteri-
(sulfamethoxazole and da® Tablet 400mg+80 mg al Agent Available
trimethoprim)

Isoniazid ----- Tablet 100mg,300 mg Antituberculosis Agent Available
Quinolone Antibacterial
Ofloxacin ----- Tablet 200mg Available
Agent
Management of anaero-
Metronidazole Flagix® Tablet 250 mg,500mg Available
bic bacterial infections
Management of Rheu-
Antimalarial Hydroxychloroquine Rheu- Tablet 200 mg matoid arthritis, and Available
Agents maqin®
Malaria
Anti-fungal Griseofulvin ---- Tablet 125,500 mg Management of Tinea Not
Agents infections Available
GlobetGut Management of diabetes
Metformin HCl Tablet 500 mg Available
® type 2
Management of diabetes
Sitagliptin ------ Tablet 25,50 mg Available
type 2
Antidiabetic
Drugs Empagliflozin Jaribet® Tablet 10 mg , 25 mg Management of diabetes Available
type 2
5 mg+ 500 mg
12/5mg+500mg Management of diabetes
Empagliflozin +metformin Jarinomet® Tablet 12/5mg+1000mg type 2 Available
186
5 mg + 1000 mg